Considerations for the Design and Conduct of Clinical Trials for Hepatitis C
Unravel Hepatitis C and Ensure Clinical Trial Success
Part of a new white paper series from PPD
"Considerations for the Design and Conduct of Clinical Trials for Hepatitis C" explores the nuances of the hepatitis C virus (HCV) that continue to impact the treatment strategies for the disease. PPD experts take a detailed look at the disease and break down the elements of a successful HCV study, including:
Learn more about PPD’s HCV and infectious disease expertise or contact us to share your feedback.